Onkologija (pedijatrija)

Individualizovana/Modifikovana hemoterapija (prilagođavanje ili odlaganje doze)

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (otvara novi prozor)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Izvor‎: N Engl J Med 1998;338(8):499-505.

Indeks‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (otvara novi prozor)

Childhood cancer and the Jehovah's Witness faith. (otvara novi prozor)

Frankel LS, Damme CJ, Eys JV.

Izvor‎: Pediatrics 1977;60(6):916-21.

Indeks‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (otvara novi prozor)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (otvara novi prozor)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Izvor‎: J Clin Oncol 2004;22(24):4888-92.

Indeks‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (otvara novi prozor)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (otvara novi prozor)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Izvor‎: JAMA Oncol 2022;8(1):79-87. 

Indeks‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (otvara novi prozor)

Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. (otvara novi prozor)

LeBlanc FR, Breese EH, Burns KC, Chang EK, Jones LM, Lee L, Mizukawa B, Norris RE, O'Brien MM, Phillips CL, Perentesis JP, Rubinstein J, Pommert L

Izvor‎: Br J Haematol 2024;205(3):1055-66.

Indeks‎: PubMed 39082439

DOI‎: 10.1111/bjh.19679

https://pubmed.ncbi.nlm.nih.gov/39082439/ (otvara novi prozor)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (otvara novi prozor)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Izvor‎: Haematologica 2000;85(11):1221-2.

Indeks‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (otvara novi prozor)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (otvara novi prozor)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Izvor‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indeks‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (otvara novi prozor)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (otvara novi prozor)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Izvor‎: Bone Marrow Transplant 2003;32(4):433-6.

Indeks‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (otvara novi prozor)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (otvara novi prozor)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Izvor‎: Bone Marrow Transplant 2005;36(8):715-20.

Indeks‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (otvara novi prozor)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (otvara novi prozor)

Zwaan CM, Kaspers GJ

Izvor‎: Br J Haematol 2004;127(3):264-79.

Indeks‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (otvara novi prozor)